TrialAnnals of oncology : official journal of the European Society for Medical Oncology2024

Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma.

N Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.